Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphineP L Dellemijn, H B Verbiest, J J van Vliet, et al.Cancer|July 1, 1992
Types and causes of pain in cancer of the head and neckC J Vecht, A M Hoff, P J Kansen, et al.Neurology|April 1, 1994
Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per dayC J Vecht, A Hovestadt, H B Verbiest, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Cisplatin-induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766F P Hamers, C Pette, B Bravenboer, et al.Neuroreport|October 6, 1998
Immunocytochemical localization of GDNF in primary afferents of the lumbar dorsal hornJ C Holstege, J L Jongen, J H Kennis, et al.Journal of Neuro-Oncology|July 27, 1999
The accumulation of topotecan in 9L glioma and in brain parenchyma with and without dexamethasone administrationC S Straathof, M J van den Bent, W J Loos, et al.Journal of Neurology|March 1, 1992
The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placeboA Hovestadt, M E van der Burg, H B Verbiest, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase I study of DABIS maleate given once every 3 weeksM E van der Burg, A S Planting, G Stoter, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1990
Diagnostic value of anti-neuronal antibodies for paraneoplastic disorders of the nervous systemJ W Moll, S C Henzen-Logmans, T A Splinter, et al.Electrophoresis|May 27, 1999
Glial fibrillary acidic protein and its fragments discriminate astrocytoma from oligodendrogliomaT M Luider, J M Kros, P A Sillevis Smitt, et al.Pageof 9